Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M59.5Revenue (TTM) $M1.4Net Margin (%)-1,661.5Altman Z-Score-15.5
Enterprise Value $M38.2EPS (TTM) $-0.7Operating Margin %-1,675.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.2Pre-tax Margin (%)-1,669.5Higher ROA y-yN
Price/Book4.210-y EBITDA Growth Rate %--Quick Ratio4.9Cash flow > EarningsY
Price/Sales38.75-y EBITDA Growth Rate %--Current Ratio4.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-82.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-125.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M34.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PSDV

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PSDVKen Fisher 2015-09-30 Buy $3.49 - $4.47
($3.92)
$ 1.74-56%New holding12,057
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PSDV is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PSDV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ross Leonard SVice President, Finance 2016-01-04Sell5,000$4.7-62.98view
Ross Leonard SVice President, Finance 2015-12-22Sell33,950$5.39-67.72view
Ashton PaulPresident & CEO 2015-12-22Sell120,000$5.39-67.72view
Ross Leonard SVice President, Finance 2015-12-01Sell1,050$4.06-57.14view
Ross Leonard SVice President, Finance 2015-08-03Sell5,000$4.05-57.04view
Ashton PaulPresident & CEO 2014-10-01Sell10,000$4.27-59.25view
Ashton PaulPresident & CEO 2014-09-02Sell10,000$4.78-63.6view
Ashton PaulPresident & CEO 2014-08-01Sell10,000$4.37-60.18view
Ashton PaulPresident & CEO 2014-07-01Sell10,000$4.32-59.72view
Ashton PaulPresident & CEO 2014-06-19Sell7,000$4-56.5view

Quarterly/Annual Reports about PSDV:

    News about PSDV:

    Articles On GuruFocus.com
    Weekly CEO Sales Highlight: pSivida Corp., Equity Residential, Ciena Corp., Sabre Corp. Dec 28 2015 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 10 2011 
    pSivida Ltd. Reports Operating Results (10-Q) Nov 09 2010 
    pSivida Ltd. Reports Operating Results (10-K) Sep 27 2010 
    pSivida Ltd. Reports Operating Results (10-Q) May 13 2010 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 12 2010 
    pSivida Ltd. Reports Operating Results (10-Q) Nov 13 2009 
    pSivida Ltd. Reports Operating Results (10-K) Sep 25 2009 
    pSivida Ltd. Reports Operating Results (10-Q) May 13 2009 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 11 2009 

    More From Other Websites
    ETFs with exposure to pSivida Corp. : December 2, 2016 Dec 02 2016
    PSIVIDA CORP. Financials Nov 17 2016
    ETF’s with exposure to pSivida Corp. : November 10, 2016 Nov 10 2016
    pSivida Corp. :PSDV-US: Earnings Analysis: Q1, 2017 By the Numbers : November 9, 2016 Nov 09 2016
    PSIVIDA CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Nov 08 2016
    Edited Transcript of PSDV earnings conference call or presentation 7-Nov-16 9:30pm GMT Nov 07 2016
    PSivida reports 1Q loss Nov 07 2016
    PSivida reports 1Q loss Nov 07 2016
    pSivida Corp. Reports Fiscal 2017 First Quarter Results and Provides Update on Corporate Objectives... Nov 07 2016
    Seasoned Ophthalmology Executive Deb Jorn Joins pSivida to Focus on Corporate and Commercial... Nov 07 2016
    PSIVIDA CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 07 2016
    pSivida Corp. Reports Fiscal 2017 First Quarter Results and Provides Update on Corporate Objectives... Nov 07 2016
    Q1 2017 pSivida Corp Earnings Release - After Market Close Nov 07 2016
    pSivida Corp. Announces First Quarter Fiscal Year 2017 Financial Results Release Date and Conference... Oct 31 2016
    pSivida Corp. Announces First Quarter Fiscal Year 2017 Financial Results Release Date and Conference... Oct 31 2016
    ETF’s with exposure to pSivida Corp. : October 28, 2016 Oct 28 2016
    ETF’s with exposure to pSivida Corp. : October 18, 2016 Oct 18 2016
    pSivida Corp. :PSDV-US: Earnings Analysis: 2016 By the Numbers : October 17, 2016 Oct 17 2016
    Phase 3 trial of Medidur™ in Posterior Segment Uveitis Meets Enrollment Target Oct 04 2016
    Phase 3 trial of Medidur™ in Posterior Segment Uveitis Meets Enrollment Target Oct 04 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)